Cargando…
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
Gynecological and breast cancers are a group of heterogeneous malignant tumors. Although existing treatment strategies have ameliorated the clinical outcomes of patients, the overall survival rate of advanced diseases remains unsatisfactory. Increasing evidence has indicated that the development and...
Autores principales: | Xu, Tianhan, Yu, Sihui, Zhang, Jiawen, Wu, Sufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557603/ https://www.ncbi.nlm.nih.gov/pubmed/34717710 http://dx.doi.org/10.1186/s13045-021-01198-9 |
Ejemplares similares
-
Emerging role of RNA sensors in tumor microenvironment and immunotherapy
por: Yang, Rui, et al.
Publicado: (2022) -
Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors
por: Gong, Yan, et al.
Publicado: (2019) -
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
por: Bertoli, Gloria, et al.
Publicado: (2016) -
The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2022) -
Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2021)